Cash And Equivalent Cambio Fecha
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amarin USD 270.81M 37.82M 2023-09
Amgen USD 10.94B 23.8B 2023-12
Baxter International USD 3.19B 2.59B 2023-12
Cara Therapeutics USD 62.88M 4.63M 2023-09
Cytokinetics USD 113.02M 13.33M 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Intra Cellular Therapies USD 147.77M 48.36M 2023-12
Intrexon USD 10.08M 6.47M 2023-09
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
MannKind USD 238.48M 155.46M 2023-12
Minerva Neurosciences USD 46.9M 4.89M 2023-09
Nektar Therapeutics USD 64.92M 14.19M 2023-09
Peregrine Pharmaceuticals USD 31.42M 6.53M 2023-09
Pfizer USD 3.15B 516M 2023-09
Rigel Pharmaceuticals USD 45.41M 3.4M 2023-09
United Therapeutics USD 1.21B 100M 2023-12
Vanda Pharmaceuticals USD 150.03M 204.14M 2023-06



Halozyme Therapeutics Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.